At the end of the activity, participants should be able to:
• Discuss recent advances in understanding autism, fragile X
syndrome, ADHD and other neurodevelopmental disorders.
• Base diagnosis and treatment of patients on the most current
information about:
° variability in the presentation of neurodevelopmental
disorders, both behaviorally and biologically
° complexity in identifying causes of disorders
• Describe how exposures to chemical pollutants prenatally
and in early childhood can disrupt healthy brain development
and how certain toxic chemicals can interact with other
environmental, socioeconomic and genetic factors.
• Discuss how to prevent exposures to neurodevelopmental
toxins on individual, community and society levels as part of a
whole systems approach to improving children’s health.
• Describe how children with neurodevelopmental disorders
may be affected by clinical levels of anxiety, and recognize
the key components of cognitive-behavioral therapy and
considerations regarding whether this treatment modality is a
good fit for a child’s current abilities and needs.